Literature DB >> 20353945

Secretory mechanisms and intercellular transfer of microRNAs in living cells.

Nobuyoshi Kosaka1, Haruhisa Iguchi, Yusuke Yoshioka, Fumitaka Takeshita, Yasushi Matsuki, Takahiro Ochiya.   

Abstract

The existence of circulating microRNAs (miRNAs) in the blood of cancer patients has raised the possibility that miRNAs may serve as a novel diagnostic marker. However, the secretory mechanism and biological function of extracellular miRNAs remain unclear. Here, we show that miRNAs are released through a ceramide-dependent secretory machinery and that the secretory miRNAs are transferable and functional in the recipient cells. Ceramide, whose biosynthesis is regulated by neutral sphingomyelinase 2 (nSMase2), triggers secretion of small membrane vesicles called exosomes. The decreased activity of nSMase2 with a chemical inhibitor, GW4869, and a specific small interfering RNA resulted in the reduced secretion of miRNAs. Complementarily, overexpression of nSMase2 increased extracellular amounts of miRNAs. We also revealed that the endosomal sorting complex required for transport system is unnecessary for the release of miRNAs. Furthermore, a tumor-suppressive miRNA secreted via this pathway was transported between cells and exerted gene silencing in the recipient cells, thereby leading to cell growth inhibition. Our findings shed a ray of light on the physiological relevance of secretory miRNAs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20353945      PMCID: PMC2878508          DOI: 10.1074/jbc.M110.107821

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

2.  Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics.

Authors:  Talal El-Hefnawy; Siva Raja; Lori Kelly; William L Bigbee; John M Kirkwood; James D Luketich; Tony E Godfrey
Journal:  Clin Chem       Date:  2004-01-12       Impact factor: 8.327

3.  Stability of endogenous and added RNA in blood specimens, serum, and plasma.

Authors:  Nancy B Y Tsui; Enders K O Ng; Y M Dennis Lo
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

4.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Authors:  J Wolfers; A Lozier; G Raposo; A Regnault; C Théry; C Masurier; C Flament; S Pouzieux; F Faure; T Tursz; E Angevin; S Amigorena; L Zitvogel
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

Review 5.  Circulating nucleic acids (CNAs) and cancer--a survey.

Authors:  M Fleischhacker; B Schmidt
Journal:  Biochim Biophys Acta       Date:  2006-10-07

6.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

7.  Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes.

Authors:  Fumitaka Takeshita; Lubna Patrawala; Mitsuhiko Osaki; Ryou-u Takahashi; Yusuke Yamamoto; Nobuyoshi Kosaka; Masaki Kawamata; Kevin Kelnar; Andreas G Bader; David Brown; Takahiro Ochiya
Journal:  Mol Ther       Date:  2009-09-08       Impact factor: 11.454

Review 8.  Stromal fibroblasts in cancer initiation and progression.

Authors:  Neil A Bhowmick; Eric G Neilson; Harold L Moses
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

Review 9.  Prospects for exosomes in immunotherapy of cancer.

Authors:  G Mignot; S Roux; Clotilde Thery; Elodie Ségura; L Zitvogel
Journal:  J Cell Mol Med       Date:  2006 Apr-Jun       Impact factor: 5.310

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  791 in total

Review 1.  Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids.

Authors:  Mohammad Amin Javidi; Amir Hossein Ahmadi; Babak Bakhshinejad; Nazila Nouraee; Sadegh Babashah; Majid Sadeghizadeh
Journal:  Med Oncol       Date:  2014-11-02       Impact factor: 3.064

2.  Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.

Authors:  Angela Montecalvo; Adriana T Larregina; William J Shufesky; Donna Beer Stolz; Mara L G Sullivan; Jenny M Karlsson; Catherine J Baty; Gregory A Gibson; Geza Erdos; Zhiliang Wang; Jadranka Milosevic; Olga A Tkacheva; Sherrie J Divito; Rick Jordan; James Lyons-Weiler; Simon C Watkins; Adrian E Morelli
Journal:  Blood       Date:  2011-10-26       Impact factor: 22.113

3.  Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism.

Authors:  Flavia Antonucci; Elena Turola; Loredana Riganti; Matteo Caleo; Martina Gabrielli; Cristiana Perrotta; Luisa Novellino; Emilio Clementi; Paola Giussani; Paola Viani; Michela Matteoli; Claudia Verderio
Journal:  EMBO J       Date:  2012-01-13       Impact factor: 11.598

Review 4.  Horizontal transfer of microRNAs: molecular mechanisms and clinical applications.

Authors:  Xi Chen; Hongwei Liang; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

5.  Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Traumatic Brain Injury.

Authors:  Hanuma Kumar Karnati; Joseph H Garcia; David Tweedie; Robert E Becker; Dimitrios Kapogiannis; Nigel H Greig
Journal:  J Neurotrauma       Date:  2018-10-25       Impact factor: 5.269

6.  Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.

Authors:  Shin-ichiro Ohno; Masakatsu Takanashi; Katsuko Sudo; Shinobu Ueda; Akio Ishikawa; Nagahisa Matsuyama; Koji Fujita; Takayuki Mizutani; Tadaaki Ohgi; Takahiro Ochiya; Noriko Gotoh; Masahiko Kuroda
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

7.  Analysis of circulating non-coding RNAs in a non-invasive and cost-effective manner.

Authors:  Yu-Min Wang; Michael Patrick Trinh; Yongzan Zheng; Kaizhu Guo; Luis A Jimenez; Wenwan Zhong
Journal:  Trends Analyt Chem       Date:  2019-07-05       Impact factor: 12.296

8.  Differential response to abiraterone acetate and di-n-butyl phthalate in an androgen-sensitive human fetal testis xenograft bioassay.

Authors:  Daniel J Spade; Susan J Hall; Camelia M Saffarini; Susan M Huse; Elizabeth V McDonnell; Kim Boekelheide
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

9.  Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p.

Authors:  Li Chen; Ruju Chen; Victoria M Velazquez; David R Brigstock
Journal:  Am J Pathol       Date:  2016-09-21       Impact factor: 4.307

Review 10.  Intercellular transport of microRNAs.

Authors:  Reinier A Boon; Kasey C Vickers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.